Coronary Artery Polymer Endostents Market to Grow with a CAGR of 5.23% through 2028
Rising aging
population with a higher risk of cardiovascular conditions is expected to drive
the Global Coronary Artery Polymer Endostents Market growth in the forecast
period, 2024-2028.
According
to TechSci Research report, “Coronary Artery Polymer Endostents Market –
Global Industry Size, Share, Trends, Competition Forecast &
Opportunities, 2028”, the Global Coronary Artery Polymer Endostents Market
stood at USD 4.32 billion in 2022 and is anticipated to grow with a CAGR of
5.23% in the forecast period, 2024-2028. One of the primary drivers propelling
the coronary artery polymer endostents market is the escalating incidence of
coronary artery disease. CAD is a widespread cardiovascular condition
characterized by the narrowing or blockage of coronary arteries, resulting in
reduced blood flow to the heart. Lifestyle factors such as poor diet, sedentary
behavior, smoking, and an aging population have contributed to the increased
prevalence of CAD globally.
As the number of individuals at risk for CAD
continues to rise, the demand for effective treatment options like polymer
endostents is also increasing. The shift towards minimally invasive procedures
is another pivotal driver of the market. Traditional coronary artery bypass
surgery is a highly invasive and complex procedure, often associated with
extended recovery times and significant risks. In contrast, polymer endostents
enable percutaneous coronary intervention (PCI) or angioplasty, a less invasive
approach. These stents can be inserted into narrowed coronary arteries,
expanding them and restoring blood flow without the need for open-heart
surgery. Patients benefit from shorter hospital stays, quicker recovery, and
reduced post-operative complications.
Continuous
technological advancements play a crucial role in driving market growth.
Manufacturers are investing heavily in research and development to create
next-generation polymer endostents that offer enhanced performance and reduced
complications. These innovations include drug-eluting stents, which release
medication to prevent restenosis (vessel renarrowing) and bioabsorbable stents
that are gradually absorbed by the body, reducing long-term risks. Improved
stent designs and delivery systems contribute to safer and more effective
procedures, further bolstering market expansion. Increasing
awareness and education campaigns about coronary artery disease risk factors
and treatment options have a significant impact on the market. As individuals
become more informed about the importance of early intervention and the
availability of minimally invasive treatments like polymer endostents, they are
more likely to seek medical care. Healthcare providers and organizations are
actively engaged in these efforts to reduce CAD-related morbidity and
mortality.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Coronary Artery Polymer Endostents Market.”
Government-led
healthcare reforms and improved insurance coverage are facilitating access to
coronary artery polymer endostents. In many countries, efforts are underway to
make essential healthcare services, including cardiac care and interventions,
more accessible and affordable. As a result, patients are more likely to
receive timely treatment with polymer endostents, boosting market demand. The growth of
the coronary artery polymer endostents market is not limited to developed
regions. Emerging markets, particularly in Asia-Pacific and Latin America, are
experiencing rapid expansion. These regions have witnessed substantial economic
growth, leading to increased healthcare spending and improved access to
advanced medical treatments. As the middle-class population expands and
healthcare infrastructure improves, the demand for coronary artery polymer
endostents is set to surge.
The Global Coronary
Artery Polymer Endostents Market is segmented into derived cell type,
application, regional distribution, and company.
Based on type,
the Global Coronary Artery Polymer Endostents Market is segmented into PLGA, PLLA,
PDLA, and Deamination Tyramine Polycarbonateeucatech. Based on the type, PLLA (Poly(L-lactic acid)
segment emerged as the dominant player in the global market for Global Coronary
Artery Polymer Endostents in 2022. PLLA has gained widespread acceptance due to
its exceptional biocompatibility, biodegradability, and mechanical properties,
making it an ideal material for use in coronary artery stents. PLLA is highly
biocompatible, meaning it is well-tolerated by the body and does not trigger
significant immune responses or adverse reactions. This is critical for stents,
as they must be compatible with the delicate cardiovascular system. PLLA is
biodegradable, meaning it gradually breaks down into non-toxic byproducts
within the body over time. PLLA exhibits favorable mechanical properties,
offering the necessary strength and flexibility for stent construction.
Based on
Application, the Global Coronary Artery Polymer Endostents Market is segmented
into Acute
Myocardial Infarction, Acute Vascular Blockage, and Other. Based on the
Application, the research segment emerged as the dominant player in the global
market for Global Coronary Artery Polymer Endostents in 2022. Based on the
Application, Acute Myocardial Infarction (AMI), segment emerged as the dominant
player in the global market for Global Coronary Artery Polymer Endostents in
2022. Coronary Artery Polymer Endostents are primarily used in the treatment of
Acute Myocardial Infarction (AMI), which is commonly referred to as a heart
attack. These
stents are specifically designed to address the blockage or narrowing of
coronary arteries that occurs during an AMI. These stents provide mechanical
support to keep the arteries open and prevent re-narrowing, ensuring that blood
flow is restored to the heart muscle. Additionally, many of these stents are
drug-eluting, meaning they release medications that inhibit tissue overgrowth
(restenosis) and reduce the risk of thrombosis (blood clots) within the stent.
North America
emerged as the dominant player in the global Coronary Artery Polymer Endostents
market in 2022, holding the largest market share. This is on account of several
key factors such as advanced healthcare infrastructure, Strong Research and
Development Ecosystem and high regulatory acceptance. North America
has a relatively high prevalence of Coronary Artery Disease, making it a
significant market for coronary artery stents. The region's aging population
and lifestyle factors like unhealthy diets and sedentary lifestyles contribute
to the incidence of CAD, driving the demand for effective treatment options. North America's
robust healthcare spending and reimbursement systems, coupled with
comprehensive insurance coverage, facilitate patient access to advanced
treatments like Coronary Artery Polymer Endostents. This financial support is
critical in making these procedures more accessible.
Major companies
operating in Global Coronary Artery Polymer Endostents Market are:
- Eucatech AG
- MicroPort Scientific Corporation
- Rontis Medical
- Meril Life Sciences
- Alvimedica Medical Technologies
- InSitu Technologies
- Elixir Medical
- SINOMED Inc
- Amaranth Medical Inc
- Amg International
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“The Global
Coronary Artery Polymer Endostents Market is poised for substantial growth in
the coming years due to several key factors. Firstly, the rising incidence of
coronary artery disease (CAD) worldwide is a significant driver of market
growth. CAD remains one of the leading causes of morbidity and mortality
globally, prompting an increasing demand for effective treatment options like
coronary artery polymer endostents. As the aging population continues to grow
and lifestyle-related risk factors persist, the market for these innovative
medical devices is expected to expand. Besides, technological advancements in
stent design and materials also play a crucial role in driving market growth.
Manufacturers are continuously investing in research and development to create
stents with improved biocompatibility, drug-eluting capabilities, and
mechanical properties.
As technology continues to evolve and healthcare systems worldwide
prioritize cardiac care, the market is expected to witness substantial
expansion in the coming years. ” said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based management consulting firm.
“Global
Coronary Artery Polymer Endostents Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast,
2018-2028 Segmented By Type (PLGA, PLLA, PDLA, Deamination Tyramine
Polycarbonateeucatech), By Application (Acute Myocardial Infarction, Acute
Vascular Blockage, Other) By Region and Competition”, has evaluated
the future growth potential of Global Coronary Artery Polymer Endostents Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Coronary Artery Polymer Endostents
Market.
Contact
Mr. Ken Mathews
708 Third
Avenue,
Manhattan, NY,
New York 10017
Tel:
+1-646-360-1656
Email: [email protected]
Website: www.techsciresearch.com